These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18034994)

  • 21. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure.
    Bourajjaj M; Armand AS; da Costa Martins PA; Weijts B; van der Nagel R; Heeneman S; Wehrens XH; De Windt LJ
    J Biol Chem; 2008 Aug; 283(32):22295-303. PubMed ID: 18477567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
    Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
    J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
    Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
    Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FHL2 binds calcineurin and represses pathological cardiac growth.
    Hojayev B; Rothermel BA; Gillette TG; Hill JA
    Mol Cell Biol; 2012 Oct; 32(19):4025-34. PubMed ID: 22851699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
    Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
    Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology.
    Cortés R; Rivera M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Azorín I; Lago F; González-Juanatey JR; Portolés M
    PLoS One; 2012; 7(2):e30915. PubMed ID: 22363514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone promotes hypertrophy of H9C2 cardiomyocytes through calcineurin B pathway, independent of NFAT activation.
    Sangeetha KN; Lakshmi BS; Niranjali Devaraj S
    Mol Cell Biochem; 2016 Jan; 411(1-2):241-52. PubMed ID: 26511233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.
    Wilkins BJ; De Windt LJ; Bueno OF; Braz JC; Glascock BJ; Kimball TF; Molkentin JD
    Mol Cell Biol; 2002 Nov; 22(21):7603-13. PubMed ID: 12370307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase RNA-like endoplasmic reticulum kinase (PERK)/calcineurin signaling is a novel pathway regulating intracellular calcium accumulation which might be involved in ventricular arrhythmias in diabetic cardiomyopathy.
    Liu Z; Cai H; Zhu H; Toque H; Zhao N; Qiu C; Guan G; Dang Y; Wang J
    Cell Signal; 2014 Dec; 26(12):2591-600. PubMed ID: 25152364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators.
    Colella M; Grisan F; Robert V; Turner JD; Thomas AP; Pozzan T
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2859-64. PubMed ID: 18287024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure.
    Rothermel BA; Berenji K; Tannous P; Kutschke W; Dey A; Nolan B; Yoo KD; Demetroulis E; Gimbel M; Cabuay B; Karimi M; Hill JA
    Physiol Genomics; 2005 Sep; 23(1):18-27. PubMed ID: 16033866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.